Back to search

Institutional Repository of Vilnius University

Nesėkmė gydant lėtinį hepatitą C tiesiogiai veikiančiais antivirusiniais vaistais, priežastys, sprendimo būdai: atvejų pristatymas ir literatūros apžvalga /

Abstract

dc:description

Hepatitis C virus infection is a global public health concern. If left untreated, chronic hepatitis C can progress gradually to cirrhosis, chronic liver failure and hepatocellular carcinoma. Treatment with new second-generation direct-acting antivirals for infection with any genotype of hepatitis C virus results in a sustained viral response rate of more than 95%. However, the treatment of certain patient groups remains challenging. The reasons for the lack of virological response with direct-acting antivirals are varied and include treatment regimen selection and adherence, drug-drug interactions, and patient- and virus-specific factors. However, the main cause of treatment failure is resistance mutations. Resistant strains are detected before the start of treatment or develop during treatment. Treatment with voxilaprevir/velpatasvir/sofosbuvir (glecaprevir/pibrentasvir + sofosbuvir) ± ribavirin for 12 weeks is currently the standard treatment for patients in whom previous combinations of direct-acting antivirals have failed. If this regimen is not available, treatment with first-generation direct-acting antivirals is available, but their efficacy is lower. In such cases, it is useful to investigate resistance mutations to optimize re-treatment. To achieve elimination of hepatitis C virus infection, it is also necessary to overcome other remaining barriers: to ensure access to treatment for all patients and to promote prevention of infection. In this work are presented four clinical cases of patients with chronic hepatitis C with treatment failures, and a discussion of possible causes and solutions.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lisaitė, Urtė,

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
lit

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Lisaitė, Urtė,. Nesėkmė gydant lėtinį hepatitą C tiesiogiai veikiančiais antivirusiniais vaistais, priežastys, sprendimo būdai: atvejų pristatymas ir literatūros apžvalga /. Institutional Repository of Vilnius University, 2023. https://repository.vu.lt/VU:ELABAETD192825535&prefLang=en_US